Evidence map›Paper›PMID 32276621›Full record

ArticleBMC ophthalmology2020

Post-intravitreal injection endophthalmitis secondary to Turicella otitidis: a case report.

Danny A Mammo, Daniel Watson, Karen R Armbrust

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Delayed-onsetAmerican journal of ophthalmology case reports · 2025
    Article
  3. Article
  4. IDCases · 2024
    Article
  5. Article
  6. BMJ case reports · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Danny A MammoDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, 420 Delaware Street Southeast, MMC 493, Minneapolis, MN, 55455, USA.
Daniel WatsonDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, 420 Delaware Street Southeast, MMC 493, Minneapolis, MN, 55455, USA.
Karen R ArmbrustDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, 420 Delaware Street Southeast, MMC 493, Minneapolis, MN, 55455, USA. karen.armbrust@va.gov.
University of Minnesota · USMinneapolis VA Health Care System · US

Funding

University of Minnesota ophthalmology teaching and research fund Not applicable
6 · The paper itself

Abstract

backgroundEndophthalmitis is a rare but potentially devastating complication of intravitreal injection. The causative organism plays an important role in prognosis following endophthalmitis. Here we present the first reported case of Turicella otitidis endophthalmitis, which is notable for a delayed presentation. CASE PRESENTATION: A 71 year old male who was receiving intravitreal aflibercept injections for neovascular age-related macular degeneration presented 4 weeks after his most recent intravitreal injection and was found to have endophthalmitis. Polymerase chain reaction (PCR) testing of aqueous fluid was positive for Turicella otitidis. The endophthalmitis responded well to treatment with intravitreal antibiotics.

conclusionsCoryneform bacteria are a rare cause of endophthalmitis, and this is the first reported case of endophthalmitis caused by the corynebacterium species Turicella otitidis. As in this case, post-intravitreal injection endophthalmitis may have a bacterial etiology even with delayed presentation. The relatively indolent disease course and excellent response to intravitreal antibiotics is consistent with previous ophthalmic reports regarding other corynebacteria, as well as with otolaryngology and hematology oncology reports addressing Turicella otitidis specifically. This case supports the growing body of evidence for pathogenicity of Turicella otitidis and demonstrates the utility of PCR for diagnosis in small volume aqueous specimens.

Indexed as

Postoperative ComplicationsAgedAngiogenesis InhibitorsAnti-Bacterial AgentsAqueous HumorCeftazidimeChoroidal NeovascularizationCorynebacteriumCorynebacterium InfectionsDrug Therapy, CombinationEndophthalmitisEye Infections, BacterialGlucocorticoidsHumansIntravitreal InjectionsMaleafliberceptAngiogenesis InhibitorsAnti-Bacterial AgentsCeftazidimeGlucocorticoidsReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsVancomycinVascular Endothelial Growth Factor AVEGFA protein, humanAfliberceptAnti-VEGFCase reportEndophthalmitisTuricella otitidis

Identifiers

PMID32276621
PMCPMC7146956
OpenAlexW3016192606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.